Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
Type:
Grant
Filed:
October 28, 2014
Date of Patent:
May 23, 2017
Assignee:
MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodendroglial and neuronal cell types.
Type:
Grant
Filed:
December 23, 2013
Date of Patent:
May 3, 2016
Assignee:
Multiple Sclerosis Research Center of New York
Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
Type:
Application
Filed:
October 28, 2014
Publication date:
April 30, 2015
Applicant:
MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
Type:
Application
Filed:
October 28, 2014
Publication date:
March 5, 2015
Applicant:
MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodendroglial and neuronal cell types.
Type:
Application
Filed:
December 23, 2013
Publication date:
October 16, 2014
Applicant:
Multiple Sclerosis Research Center of New York
Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
Type:
Grant
Filed:
November 2, 2007
Date of Patent:
February 4, 2014
Assignee:
Multiple Sclerosis Research Center of New York
Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
Type:
Application
Filed:
June 9, 2011
Publication date:
September 29, 2011
Applicant:
MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
Abstract: Biomarkers are disclosed that facilitate the mechanisms associated with central nervous system disease worsening or activity, specifically multiple sclerosis. Methods are also disclosed for identification of biomarkers associated with disease worsening or activity in multiple sclerosis.
Type:
Grant
Filed:
September 17, 2007
Date of Patent:
September 7, 2010
Assignee:
Multiple Sclerosis Research Center of New York
Inventors:
Saud Ahmed Sadiq, Nicola Renee Donelan, Qi Jiang Yan
Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
Type:
Application
Filed:
November 2, 2007
Publication date:
July 1, 2010
Applicant:
MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
Abstract: Biomarkers are disclosed that facilitate the mechanisms associated with central nervous system disease worsening or activity, specifically multiple sclerosis. Methods are also disclosed for identification of biomarkers associated with disease worsening or activity in multiple sclerosis.
Type:
Application
Filed:
September 17, 2007
Publication date:
October 30, 2008
Applicant:
Multiple Sclerosis Research Center of New York
Inventors:
Saud Ahmed Sadiq, Nicola Renee Donelan, Qi Jiang Yan